India aims for greater market access for pharma in UK: Official

"The best part in the proposed agreement is that both sides have highlighted their red lines and sensitivities. Ever-greening and touching manufacturing of generic medicines is completely non-negotiable," the official added.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/BUJkogM
via IFTTT